LEVELS OF TESTOSTERONE AND SOMATOTROPIC HORMONE IN MALE COMBATANTS DEPENDING ON THE VOLUME OF BODY WOUND DAMAGE
DOI:
https://doi.org/10.21856/j-PEP.2024.4.06Keywords:
post-traumatic stress disorder, wounds, body damage, war, somatotropic hormone, testosterone, menAbstract
Post-traumatic stress disorder (PTSD) affects approximately 8% of the general population. The prevalence of PTSD is twice as high among military personnel and combat veterans. PTSD is associated with a variety of social or personal health problems. Although the development of this disorder as a result of relationship difficulties has been studied more broadly, less is known about the relationship between PTSD and sexual dysfunction.
The aim of the study was to determine the main regularities between the volume of wound damage (on the one hand) and changes in the levels of some hormones in blood serum at different stages of wound disease (on the other hand), taking into account that these changes are important components of general processes that determine the course of the wound process.
Materials and methods. 30 men who received soft tissue injuries of various sizes took part in the study. The age of the wounded is 34.2 ± 4.3 years. The average body weight was 78 ± 3.5 kg. The levels of somatotropic hormone (STH) and testosterone were determined.
The results. During the study, a probable (p<0.05) increase in STH was registered in the group of patients with mild injuries from the first day after the injury. Such high levels of THG in male combatants were observed throughout the study. In the group of patients with an injury of moderate severity, we observed a significant (p<0.05) increase in the level of THG, which began on the first day and remained at a high level until the 5th day after the injury. But after two weeks, the concentration of growth hormone decreased almost to the level of control indicators. In the group of severely wounded, we registered a significant difference in indicators depending on the day of injury.
The dynamics of testosterone levels, which was obtained in the study, fully corresponds to the data of the literature regarding the fact that severe damage is almost always accompanied by suppression of the function of the gonads, which is manifested by a decrease in testosterone production, which increases anabolic processes.
In our study, the rather low level of testosterone in all young men with moderate and severe injuries draws attention. At the same time, it should be noted that the level of testosterone in men with light injuries did not differ from the control group.
Conclusions. First, the dependence of the levels of somatotropic hormone and testosterone on the severity of the injury in male combatants was established. Secondly, the role of testosterone and somatotropic hormone in the development of post-traumatic stress disorder and sexual dysfunction in male combatants was confirmed.
Key words: post-traumatic stress disorder, wounds, body damage, war, somatotropic hormone, testosterone, men.
References
Hannan SM, Thomas KB, Allard CB. J Interpers Violence 2021;36(17-18): NP10035-NP10054. http://doi.org/10.1177/0886260519864355.
Sayer NA, Chiros CE, Sigford B, et al. Arch Phys Med Rehabil 2008;89: 163-170. http://doi.org/10.1016/j.apmr.2007.05.025
Katherine H Taber, et al. J Neuropsychiatry Clin Neurosci 2009. https://doi.org/10.1176/jnp.2009.21.1.iv
Gawande A. N Engl J Med 2004;351: 2471-2475. http://doi.org/10.1056/NEJMp048317
Raza Z, Hussain SF, Foster VS, et al. Front Epidemiol 2023;3: 1066158. http://doi.org/10.3389/fepid.2023.1066158.
Dengler BA, Agimi Y, Stout K, et al. J Trauma Acute Care Surg 2022;93: 220-228. http://doi.org/10.1097/TA.0000000000003497
Kim SY, Soumoff AA, Raiciulescu S, et al. Neurotrauma Rep 2023;4(1): 14-24. http://doi.org/10.1089/neur.2022.0063.
Glenn JJ, Dillon KH, Dennis PA, et al. Suicide Life-Threatening Behav 2020;50: 1167-1172. http://doi.org/10.1111/sltb.12678.
Nnamani NS, Pugh MJ, Amuan ME, et al. Mil Med 2019;184: E297-E301. http://doi.org/10.1093/milmed/usy196.
Breyer BN, Cohen BE, Bertenthal D, et al. J Sex Med 2014;11(1): 75-83. http://dx.doi.org/10.1111/jsm.12201.
Yehuda R, Lehrner A, Rosenbaum T. J Sex Med 2015;12(5): 1107-1119. http://dx.doi.org/10.1111/jsm. 12856.
Zoladz PR, Diamond DM. Neurosci Biobehav Rev 2013;37(5): 860-895. http://doi.org/10.1016/j.neubiorev.2013.03.024
Song Y, Zhou D, Wang X. Psychoneuroendocrinology 2008;33: 1155-1159. http://doi.org/10.1016/j.psyneuen.2008.05.005.
Steyn FJ, Tolle V, Chen C, Epelbaum J. Compr Physiol 2016;6: 687-735. http://doi.org/10.1002/cphy.c150002.
Laron Z. Mol Pathol 2001;54: 311. http://doi.org/10.1136/mp.54.5.311.
Rabkin R, Fervenza FC, Maidment H, et al. Kidney Int 1996;49: 1134-1140. http://doi.org/10.1038/ki.1996.164.
Donato Jr, Wasinski F, Furigo IC, et al. Cells 2021;10: 129. http://doi.org/10.3390/cells10010129.
Dehkhoda F, Lee CM, Medina J, Brooks AJ. Front Endocrinol 2018;9: 35. http://doi.org/10.3389/fendo.2018.00035.
van Liempt S, Vermetten E, Lentjes E, et al. Psychoneuroendocrinology 2011;36: 1361-1369. http://doi.org/10.1016/j.psyneuen.2011.03.009.
Raise-Abdullahi P, Meamar M, Vafaei AA, et al. Brain Sci 2023;13(7): 1010. http://doi.org/10.3390/brainsci13071010.
Viau V. J Neuroendocrinol 2002;14: 506-513. http://doi.org/10.1046/j.1365-2826.2002.00798.x.
Bird ER, Piccirillo M, Garcia N, et al. J Sex Med 2021;18(8): 1398-1426. http://doi.org/10.1016/j.jsxm.2021.05.011.
Voigt K, Ziegler M, Grünert-Fuchs M, et al. Psychoneuroendocrinology 1990;15: 173-184. http://doi.org/10.1016/0306-4530(90)90028-8.
Mulchahey JJ, Ekhator NN, Zhang H, et al. Psychoneuroendocrinology 2001;26: 273-285. http://doi.org/10.1016/S0306-4530(00)00052-4.
Inna Feklicheva, Marco P. Boks, E. Ron de Kloet, et al. J Psychiatric Res 2022; 148: 258-263. http://doi.org/10.1016/j.jpsychires.2021.11.032.
Leranth C, Hajszan T, MacLusky NJ. J Neurosci 2004;24: 495-499. http://doi.org/10.1523/JNEUROSCI.4516-03.2004.
Durdiakova J, Ostatnikova D, Celec P. Acta Neurobiol Exp 2011;71: 434-454. http://doi.org/10.55782/ane-2011-1863
Handa RJ, Weiser MJ. Front Neuroendocrinol 2014;35: 197-220. http://doi.org/10.1016/j.yfrne.2013.11.001.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Problems of Endocrine Pathology

This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN
ISSN 






